Key points are not available for this paper at this time.
This Medical News article discusses Wegovy, Ozempic, and other GLP-1 receptor agonists used for weight management and type 2 diabetes.
Share your take
Add a clinician perspective alongside expert commentary.
Kate Ruder (2023) studied this question.